Clinical Trials Browser

Phase 1 × Carcinoma, Basal Cell × cemiplimab × Clear all

NCT03889912 2026-01-21

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

Phase 1 Completed

Carcinoma, Basal Cell